Lpath, Inc. Press Releases

LPTN 
$3.0101
*  
0.0001
0%
Get LPTN Alerts
*Delayed - data as of Oct. 24, 2014 14:36 ET  -  Find a broker to begin trading LPTN now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    LPTN Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By
Lpath Granted Key European Patent Related to iSONEP and ASONEP Programs
10/20/2014 8:00:00 AM - PR Newswire
▼-1.95 % Price Change since this news event. The Volume Ratio is 0.57.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Lpath, Inc. Announces Closing of $12.5 Million Registered Direct Offering
9/29/2014 8:30:00 AM - PR Newswire


Actavis Confirms Generic Butrans® Patent Challenge
9/25/2014 4:05:00 PM - PR Newswire


Lpath to Present at the 13th Annual BIO Investor Forum
9/25/2014 4:05:00 PM - PR Newswire


Lpath, Inc. Announces $12.5 Million Registered Direct Offering
9/19/2014 8:30:00 AM - PR Newswire


Lpath to Present at 34th Annual Canaccord Genuity Growth Conference
8/11/2014 8:00:00 AM - PR Newswire